Efficacy of early cardiac rehabilitation after acute myocardial infarction: Randomized clinical trial protocol.
Caroline SchonAmanda FelisminoJoceline de SáRenata CorteTatiana Souza RibeiroSelma BrunoPublished in: PloS one (2024)
The acute myocardial infarction (AMI) present high mortality rate that may be reduced with cardiac rehabilitation. Despite its good establishment in outpatient care, few studies analyzed cardiac rehabilitation during hospitalization. Thus, this study aims to clarify the safety and efficacy of early cardiac rehabilitation after AMI. This will be a clinical, controlled, randomized trial with blind outcome evaluation and a superiority hypothesis. Twenty-four patients with AMI will be divided into two groups (1:1 allocation ratio). The intervention group will receive an individualized exercise-based cardiac rehabilitation protocol during hospitalization and a semi-supervised protocol after hospital discharge; the control group will receive conventional care. The primary outcomes will be the cardiac remodeling assessed by cardiac magnetic resonance imaging, functional capacity assessed by maximal oxygen consumption, and cardiac autonomic balance examined via heart rate variability. Secondary outcomes will include safety and the total exercise dose provided during the protocol. Statistical analysis will consider the intent-to-treat analysis. Trial registration. Trial registration number: Brazilian Registry of Clinical Trials (ReBEC) (RBR- 9nyx8hb).
Keyphrases
- acute myocardial infarction
- heart rate variability
- left ventricular
- randomized controlled trial
- clinical trial
- heart rate
- percutaneous coronary intervention
- magnetic resonance imaging
- healthcare
- study protocol
- phase ii
- phase iii
- palliative care
- resistance training
- physical activity
- type diabetes
- machine learning
- computed tomography
- pain management
- blood pressure
- open label
- coronary artery disease
- metabolic syndrome
- acute coronary syndrome
- affordable care act
- double blind
- weight loss
- placebo controlled